4DX:ASX
4DMedical Ltd
A$4.76
arrow_downward
-9.68%(-0.51) 1D
Abr 24, 4:10:25 PM GMT+10 · AUD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 4DX...
Buksan
A$5.20
Mataas
A$5.20
Mababa
A$4.76
Mkt. cap
2.81B
Avg. na dami
8.85M
Dami
7.01M
Mataas nang 52-wk
A$7.55
Mababa nang 52-wk
A$0.23
EPS
-A$0.34
Mga natitirang share
590.57M
Bilang ng mga empleyado
124
Mga balita at kwento
Mula sa mga source sa buong web
Yahoo Finance
·
1 araw ang nakalipas
4DMedical GSK Lung Imaging Deal And What It May Mean For Investors
Simply Wall Street
·
2 araw ang nakalipas
A Look At 4DMedical’s (ASX:4DX) Valuation After Its New GlaxoSmithKline Lung Imaging Contract
Profile
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Tungkol sa 4DMedical Ltd
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa